DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Palma DA. et al.
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.
Lancet 2019;
393: 2051-2058
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.